Beta Delta

Can Steve Jobs's Case Help Propel Biopharma?

mike, you should do some due diligence on genvec and their tnferade drug. this drug has the potential to be the next major breakthrough in the treatment of solid tumor carcinoma's, especially pancreatic, for which its in mid to late phase 3 trial. data from its interim look after 92 deaths showed a marked improvement in survival between 12 and 18 months

beta